XML 21 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities    
Net loss $ (3,279) $ (2,966)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 2 1
Stock-based compensation 1,289 19
Unrealized loss on marketable equity securities 33
Amortization of discounts and issuance costs related to convertible loans 1,122
Amortization of premium related to convertible loans (Notes 8 and 13) (2,149)
Accrued interest on convertible loans (Notes 8 and 13) 56 47
Loss from extinguishment of convertible loans (Notes 8 and 13) 1,709 61
Change in the fair value of derivative liability for right to future investment (Notes 8 and 13) 246
Change in the fair value of license purchase obligation (Note 6) 3
Change in:    
Other current assets (86) (33)
Trade payables (9) 30
Other accounts payable 76 (40)
License purchase obligation 150 146
Net cash used in operating activities (2,208) (1,364)
Cash flows from investing activities    
Purchase of property and equipment (5) (4)
Proceeds from sale of marketable equity securities 258
Net cash provided by (used in) investing activities 253 (4)
Cash flows from financing activities    
Proceeds from loans from controlling stockholder 82
Proceeds from issuance of convertible loans, net of issuance costs (Note 8) 625
Proceeds from issuance of shares with respect to exercise of PIPE warrants and right for future investment 1,145
Proceeds from issuance of units consisting of common stock, preferred stock A and warrants (Note 12c) 3,915 966
Proceeds from exercise of options into common stock 21
Repayment of license purchase obligation (150) (156)
Net cash provided by financing activities 4,910 1,538
Effect of exchange rate change on cash, cash equivalents and restricted cash 1 17
Change in cash, cash equivalents and restricted cash 2,956 187
Cash, cash equivalents and restricted cash at the beginning of the year 227 40
Cash, cash equivalents and restricted cash at the end of the year 3,183 227
Supplemental disclosure of non-cash financing activities:    
Classification of derivative liability for right to future investment into equity 280
Acquisition of marketable equity securities as part of the recapitalization 298
Increase in other current assets through equity 54
Deemed dividend with respect to the repurchase of right for future investment 292 3
Conversion of Preferred stock into Common stock
Amount allocated to the repurchase of beneficial conversion feature in convertible loans (1,918) (2,800)
Amount allocated to the right for future investment - loan 2016 upon 2018 modification 952
Amount allocated to the right for future investment - loan 2017 upon 2018 modification $ 1,444